Looks like it's approved for clearing of amyloid plaque in the brain. Biogen now has to "prove" that the removal of amyloid plaque leads to slowing of the AD. This is nest possible outcome for Cogstate imo.
5 Weeks until Aducanumab PDUFA date, page-13
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.025(2.31%) |
Mkt cap ! $188.7M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.11 | $1.07 | $63.06K | 58.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3351 | 1 |
View Market Depth
| Last trade - 15.29pm 05/07/2024 (20 minute delay) ? |
| CGS (ASX) Chart |